Logo

People in the News: Jennifer Doudna, Vasant Jadhav

Feb 27, 2014
Premium

University of California, Berkeley researcher Jennifer Doudna has been awarded the Lurie Prize in the Biomedical Sciences by the Foundation for the National Institutes of Health.

Doudna received the honor for her work on RNA and the discovery of the gene-editing process known as CRISPR. The award includes a $100,000 prize.

Vasant Jadhav has joined Alnylam Pharmaceuticals as senior director of research.

He previously served as a director of research at Merck, focusing on that company's efforts to develop an siRNA conjugate delivery platform.

Alnylam acquired Merck's RNAi assets this year.

Filed under

Gene Editing, Gene Silencing, & CRISPR
UC Berkeley
RNAi
Alnylam
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.